KORU Medical Systems (NASDAQ:KRMD) and Phreesia (NYSE:PHR) Critical Comparison

Phreesia (NYSE:PHRGet Free Report) and KORU Medical Systems (NASDAQ:KRMDGet Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Phreesia and KORU Medical Systems, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phreesia 1 1 17 0 2.84
KORU Medical Systems 1 1 4 0 2.50

Phreesia presently has a consensus target price of $28.65, indicating a potential upside of 161.47%. KORU Medical Systems has a consensus target price of $6.50, indicating a potential upside of 54.03%. Given Phreesia’s stronger consensus rating and higher possible upside, analysts plainly believe Phreesia is more favorable than KORU Medical Systems.

Risk & Volatility

Phreesia has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500.

Valuation & Earnings

This table compares Phreesia and KORU Medical Systems”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Phreesia $419.81 million 1.57 -$58.53 million ($0.10) -109.56
KORU Medical Systems $41.13 million 4.76 -$2.64 million ($0.06) -70.33

KORU Medical Systems has lower revenue, but higher earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than KORU Medical Systems, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 5.5% of Phreesia shares are owned by company insiders. Comparatively, 20.6% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Phreesia and KORU Medical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Phreesia -1.16% -1.31% -0.94%
KORU Medical Systems -6.41% -15.90% -9.77%

Summary

Phreesia beats KORU Medical Systems on 9 of the 14 factors compared between the two stocks.

About Phreesia

(Get Free Report)

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About KORU Medical Systems

(Get Free Report)

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.